Clinical Trials in Minneapolis

Showing 6721-6740 of 11,007 trials

Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation

NCT03489408

The purpose of this study is to collect device and procedure experience in everyday clinical practice. The patients are being asked to participate in this study because they are a surgical candidate for the treatment of a broken shoulder and are considering treatment with the PH Cage device.

Humeral Fractures, Proximal

Conventus Orthopaedics, Inc.40 participantsStarted Feb 2018

Redwood City, California, United States • Torrance, California, United States • Baltimore, Maryland, United States +2 more locations

COMPLETEDPhase 1/2< 1 mile

ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL

NCT02141451

This is a single institution phase I/II study using an ADAM17 inhibitor (INCB7839) with rituximab as consolidation therapy after an autologous hematopoietic cell transplant (HCT) for patients with diffuse large B cell lymphoma (DLBCL). The study consists of two phases. The dose finding phase is a modified version of a phase I trial and the extended phase is a modified version of a phase II trial.

Diffuse Large B Cell Non-Hodgkin Lymphoma

Masonic Cancer Center, University of Minnesota30 participantsStarted May 2014

Minneapolis, Minnesota, United States

COMPLETEDPhase 2< 1 mile

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

NCT02161406

The study hypothesis is that SC abatacept is safe and shows evidence of efficacy (improvement in modified Rodnan score \[mRSS\]) in patients with diffuse cutaneous systemic sclerosis (dcScc) compared to matching placebo.

Diffuse Cutaneous Systemic Sclerosis

Dinesh Khanna, MD, MS88 participantsStarted Sep 2014

Los Angeles, California, United States • Los Angeles, California, United States • Redwood City, California, United States +24 more locations

Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation

ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Find Trials by Condition in Minneapolis

Flexitouch Treatment for Venous Ulcers

Modulating Human Cortical Plasticity With Transcranial Electrical Stimulation

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

Assessment of Ventilatory Management During General Anesthesia for Robotic Surgery

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

A Phase 3 Study of Tanezumab for Chronic Low Back Pain

Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)

Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction

Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State